Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
B Banwell, JL Bennett, R Marignier, HJ Kim… - The Lancet …, 2023 - thelancet.com
Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …
Myelin-oligodendrocyte glycoprotein antibody-associated disease
R Marignier, Y Hacohen, A Cobo-Calvo… - The Lancet …, 2021 - thelancet.com
Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently
identified autoimmune disorder that presents in both adults and children as CNS …
identified autoimmune disorder that presents in both adults and children as CNS …
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …
most recently defined inflammatory demyelinating disease of the central nervous system …
Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment
Optic neuritis is an inflammatory optic neuropathy that is commonly indicative of autoimmune
neurological disorders including multiple sclerosis, myelin-oligodendrocyte glycoprotein …
neurological disorders including multiple sclerosis, myelin-oligodendrocyte glycoprotein …
A review of cytokine-based pathophysiology of Long COVID symptoms
RN Low, RJ Low, A Akrami - Frontiers in medicine, 2023 - frontiersin.org
The Long COVID/Post Acute Sequelae of COVID-19 (PASC) group includes patients with
initial mild-to-moderate symptoms during the acute phase of the illness, in whom recovery is …
initial mild-to-moderate symptoms during the acute phase of the illness, in whom recovery is …
The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
We sought to define the pathological features of myelin oligodendrocyte glycoprotein (MOG)
antibody associated disorders (MOGAD) in an archival autopsy/biopsy cohort. We …
antibody associated disorders (MOGAD) in an archival autopsy/biopsy cohort. We …
Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder
Objective Myelin oligodendrocyte glycoprotein–immunoglobulin G (MOG-IgG) associated
disorder (MOGAD) often manifests with recurrent CNS demyelinating attacks. The optimal …
disorder (MOGAD) often manifests with recurrent CNS demyelinating attacks. The optimal …
Optic neuritis
JL Bennett - Continuum: lifelong learning in neurology, 2019 - journals.lww.com
PURPOSE OF REVIEW This article discusses the clinical presentation, evaluation, and
management of the patient with optic neuritis. Initial emphasis is placed on clinical history …
management of the patient with optic neuritis. Initial emphasis is placed on clinical history …
Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids
Y Matsumoto, K Kaneko, T Takahashi, Y Takai… - Brain, 2023 - academic.oup.com
The spectrum of MOG-IgG-associated disease (MOGAD) includes optic neuritis (ON),
myelitis (MY), acute disseminated encephalomyelitis (ADEM), brainstem encephalitis …
myelitis (MY), acute disseminated encephalomyelitis (ADEM), brainstem encephalitis …
[HTML][HTML] EU paediatric MOG consortium consensus: Part 1–Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated …
AL Bruijstens, C Lechner, L Flet-Berliac, K Deiva… - European Journal of …, 2020 - Elsevier
Over the past few years, increasing interest in the role of autoantibodies against myelin
oligodendrocyte glycoprotein (MOG-abs) as a new candidate biomarker in demyelinating …
oligodendrocyte glycoprotein (MOG-abs) as a new candidate biomarker in demyelinating …